Order results by:
Issue | Title | |
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
"... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
"... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
S. E. Belov, A. N. Boyko | ||
"... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..." | ||
Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
"... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
"... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..." | ||
Vol 11, No 3 (2019) | Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis | Abstract similar documents |
A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko | ||
"... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..." | ||
Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
"... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
"... give their own experience of its use in the Moscow Multiple Sclerosis Center. Objective: to assess ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
"... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..." | ||
Vol 11, No 3 (2019) | Mitochondrial genome and risk of multiple sclerosis | Abstract similar documents |
A. N. Boyko, M. S. Kozin, G. Zh. Osmak, O. G. Kulakova, O. O. Favorova | ||
"... risk of multiple sclerosis (MS). Objective: to analyze the frequency of mtDNA variants in patients ..." | ||
Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
"... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
"... One of the promising areas in the pathogenetic treatment of multiple sclerosis (MS) is anti-B-cell ..." | ||
Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
"... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..." | ||
Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
T. E. Shmidt | ||
"... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..." | ||
Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis | Abstract PDF (Eng) similar documents |
M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
"... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..." | ||
Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
"... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..." | ||
Vol 12, No 3 (2020) | Anti-MOG associated myelitis | Abstract PDF (Eng) similar documents |
A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko | ||
"... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..." | ||
1 - 18 of 18 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)